LEADING MEDICAL RESEARCH IN CGD
The research we fund is at the cutting edge, often exploring solutions that will take many years to refine and apply clinically. Research
that helps CGD sufferers can benefit millions more. CGD fortunately attracts great interest among top research teams due to being a single-gene deficiency, meaning any breakthroughs in CGD are more likely to shed light on how other genetic disorders work. CGD might otherwise face a serious problem attracting funding and attention.
Selecting the most promising projects
It is in the nature of research that some avenues yield no useful results, but CGD RT is very careful where we put donors’ money. Every application received in fully peer reviewed by external experts who pass on their advice to our dedicated Medical Advisory Committee. This Committee then decides which projects would give the best scientific outcomes for CGD and the best value for money. This Committee is assisted by our Research Officer Dr Susan Walsh. Equally importantly, we demand absolute clarity regarding how grants were spent, and monitor and evaluate carefully.
We are well connected with the biggest names in research in our field; with key hospitals, research establishments, scientists and medical professionals. We keep up a dialogue with other top bodies to maximize impact and avoid duplication of research. We are transparent and accountable, happy to provide details of exactly how research projects spent the money you gave us.
IMPORTANT NOTE :
The information contained on this website is intended only as a guideline, not as a substitute for medical advice. Always consult your doctor if you or your child has any CGD symptoms or concerns.
© 2001-2005 The Chronic Granulomatous Disorder (CGD) Research
Trust
Registered Charity No. 1003425 email:cgd@cgdrt.co.uk
The CGD Research Trust is a member of the Association of Medical Research Charities (AMRC), the Genetic Interest Group (GiG) and an associate member of the International Patient Organisation of Primary Immunodeficiencies (IPOPI)
Terms and Conditions | Privacy
